Sebastian Schneeweiss, Sc.D., M.D.
Co-Author
This page shows the publications co-authored by Sebastian Schneeweiss and Alec Walker.
Connection Strength
2.545
-
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study. J Antimicrob Chemother. 2016 10; 71(10):2938-44.
Score: 0.670
-
Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008 Feb 21; 358(8):771-83.
Score: 0.374
-
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ. 2002 Mar 19; 166(6):737-45.
Score: 0.248
-
Removal of ineligible outcome cases reduces confounding. Clin Epidemiol. 2018; 10:575-579.
Score: 0.190
-
Reuse of data sources to evaluate drug safety signals: When is it appropriate? Pharmacoepidemiol Drug Saf. 2018 06; 27(6):567-569.
Score: 0.190
-
Sequential surveillance for drug safety in a regulatory environment. Pharmacoepidemiol Drug Saf. 2018 07; 27(7):707-712.
Score: 0.188
-
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems. Pharmacoepidemiol Drug Saf. 2014 Nov; 23(11):1223-5.
Score: 0.148
-
Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules. Epidemiology. 2012 Mar; 23(2):238-46.
Score: 0.124
-
An event-based approach for comparing the performance of methods for prospective medical product monitoring. Pharmacoepidemiol Drug Saf. 2012 Jun; 21(6):631-9.
Score: 0.122
-
Effect of aprotinin on renal dysfunction. Lancet. 2008 Jul 05; 372(9632):26; author reply 26-7.
Score: 0.096
-
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther. 2003 Oct; 74(4):388-400.
Score: 0.069
-
Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol. 2002 Aug; 55(8):833-41.
Score: 0.064
-
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med. 2002 Mar 14; 346(11):822-9.
Score: 0.062
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.